Elevance Health, Inc.
Informe acción WBAG:ELV
Capitalización de mercado: €92.0b
Elevance Health Dirección
Dirección controles de criterios 3/4 Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Gail Boudreaux
Chief Executive Officer (CEO)
US$21.9m
Compensación total
Porcentaje del salario del CEO 7.3% Permanencia del CEO 7yrs Participación del CEO 0.05% Permanencia media de la dirección 6.8yrs Promedio de permanencia en la Junta Directiva 11.3yrs
Actualizaciones recientes de la dirección
Insider recently sold €3.0m worth of stock Oct 20
Insider recently sold €6.4m worth of stock Apr 28
Insider recently sold €1.1m worth of stock Mar 13
Elevance Health, Inc., Annual General Meeting, May 15, 2024 Feb 19 Elevance Health, Inc. Announces Executive Changes
Elevance Health, Inc., Annual General Meeting, May 10, 2023 Feb 18
Mostrar todas las actualizaciones
Investor sentiment deteriorates as stock falls 15% Oct 24
Insider recently sold €3.0m worth of stock Oct 20
Third quarter dividend of US$1.63 announced Oct 20
Elevance Health, Inc. (NYSE:ELV) agreed to acquire CareBridge Medical Group, P.C. Oct 18
Third quarter 2024 earnings released: EPS: US$4.36 (vs US$5.48 in 3Q 2023) Oct 17 Elevance Health, Inc. Declares Dividend for the Fourth Quarter of 2024, Payable on December 20, 2024
Las Mercedes Medical Centers acquired Pasteur and Wellmax Medical Centers from Elevance Health, Inc. (NYSE:ELV). Oct 08
Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024 Oct 07
Upcoming dividend of US$1.63 per share Sep 03
Clayton, Dubilier & Rice and Elevance Health Announces the Introduction of Mosaic Health, a National Care Delivery Platform Aug 14
Second quarter dividend of US$1.63 announced Jul 19
Second quarter 2024 earnings released: EPS: US$9.85 (vs US$7.83 in 2Q 2023) Jul 18
Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024 Jul 17
Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024 Jun 27
Upcoming dividend of US$1.63 per share Jun 03
Insider recently sold €6.4m worth of stock Apr 28
First quarter dividend of US$1.63 announced Apr 24 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024
First quarter 2024 earnings released: EPS: US$9.59 (vs US$8.38 in 1Q 2023) Apr 18
Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024 Apr 04 StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc. Apr 02
Insider recently sold €1.1m worth of stock Mar 13
Upcoming dividend of US$1.63 per share Feb 29
Full year 2023 earnings released: EPS: US$25.38 (vs US$24.56 in FY 2022) Feb 23
Elevance Health, Inc., Annual General Meeting, May 15, 2024 Feb 19
Fourth quarter dividend of US$1.63 announced Jan 29
Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024 Jan 26
Full year 2023 earnings released: EPS: US$25.22 (vs US$25.10 in FY 2022) Jan 25
Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024 Jan 24
Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024 Jan 11
Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services Jan 10
Upcoming dividend of US$1.48 per share at 1.2% yield Nov 28
Third quarter 2023 earnings released: EPS: US$5.48 (vs US$6.75 in 3Q 2022) Oct 20 Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023
Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023 Oct 05
Upcoming dividend of US$1.48 per share at 1.3% yield Aug 31 Elevance Health, Inc. Announces Executive Changes Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023
Second quarter 2023 earnings released: EPS: US$7.79 (vs US$6.87 in 2Q 2022) Jul 20
Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023 Jun 29
New minor risk - Share price stability Jun 18
Upcoming dividend of US$1.48 per share at 1.3% yield Jun 01
First quarter 2023 earnings released: EPS: US$8.30 (vs US$7.48 in 1Q 2022) Apr 20
Upcoming dividend of US$1.48 per share at 1.3% yield Mar 02
Elevance Health, Inc., Annual General Meeting, May 10, 2023 Feb 18
Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx. Feb 16
Full year 2022 earnings released: EPS: US$24.82 (vs US$25.04 in FY 2021) Jan 26 Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023
Elevance Health Inc. (NYSE:ELV) entered into a definitive agreement Louisiana Health Service and Indemnity Company. Jan 24
Elevance Health Inc. to Report Q4, 2022 Results on Jan 25, 2023 Jan 12
Upcoming dividend of US$1.28 per share Nov 25
Insufficient new directors Nov 16
Elevance Health Inc. (NYSE:ELV) entered into an agreement to acquire BioPlus Specialty Pharmacy Services, LLC from CarepathRx. Nov 10
Elevance Health, Inc. Appoints Deanna Strable-Soethout as an Independent Director, Effective November 1, 2022 Oct 26
Third quarter 2022 earnings released Oct 21
Elevance Health Inc. Provides Earnings Guidance for Full Year 2022 Oct 20
Elevance Health Inc. to Report Q3, 2022 Results on Oct 19, 2022 Oct 06
Upcoming dividend of US$1.28 per share Sep 01
Second quarter 2022 earnings released: EPS: US$6.79 (vs US$7.33 in 2Q 2021) Jul 21 Elevance Health Inc. Declares Third Quarter 2022 Dividend, Payable on September 23, 2022
Elevance Health Inc. to Report Q2, 2022 Results on Jul 20, 2022 Jul 07
Independent Director recently sold €195k worth of stock Jun 09
Upcoming dividend of US$1.28 per share Jun 02
Anthem, Inc. (NYSE:ANTM) completed the acquisition of Integra MLTC, Inc. from Personal-Touch Home Care, Inc. May 06
Insufficient new directors Apr 27
Anthem, Inc. Provides Earnings Guidance for the Year 2022 Apr 24
First quarter 2022 earnings released: EPS: US$7.39 (vs US$6.80 in 1Q 2021) Apr 21
Anthem, Inc. Declares Second Quarter 2022 Dividend, Payable on June 24, 2022 Apr 21
Anthem, Inc. to Report Q1, 2022 Results on Apr 20, 2022 Apr 07
Senior VP recently sold €363k worth of stock Mar 12
Upcoming dividend of US$1.28 per share Mar 02
Anthem, Inc., Annual General Meeting, May 18, 2022 Feb 19
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Jan 27
Anthem, Inc. Provides Earnings Guidance for the Full Year of 2022 Jan 27
Upcoming dividend of US$1.13 per share Nov 25
Third quarter 2021 earnings released: EPS US$6.20 (vs US$0.88 in 3Q 2020) Oct 22
Upcoming dividend of US$1.13 per share Sep 02
Insider recently bought €425k worth of stock Jul 28
Second quarter 2021 earnings released: EPS US$7.33 (vs US$9.03 in 2Q 2020) Jul 23
Anthem, Inc. Provides Earnings Guidance for the Year 2021 Jul 23 Anthem, Inc.(NYSE:ANTM) dropped from Russell 3000 Growth Index
Upcoming dividend of US$1.13 per share Jun 02
Independent Director recently sold €422k worth of stock May 26
Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy May 21
Anthem, Inc. Enables Secure Exchange of Health Information to Enhance Healthcare Experience May 20
Anthem, Inc. Provides Financial Guidance for Fiscal 2021 Apr 24
First quarter 2021 earnings released: EPS US$6.80 (vs US$6.03 in 1Q 2020) Apr 24
Senior VP recently sold €580k worth of stock Mar 10
New 90-day high: €283 Mar 09
Análisis de compensación del CEO ¿Cómo ha cambiado la remuneración de Gail Boudreaux en comparación con los beneficios de Elevance Health? Fecha Compensación total Salario Ingresos de la empresa Sep 30 2024 n/a n/a US$6b
Jun 30 2024 n/a n/a US$7b
Mar 31 2024 n/a n/a US$6b
Dec 31 2023 US$22m US$2m US$6b
Sep 30 2023 n/a n/a US$6b
Jun 30 2023 n/a n/a US$6b
Mar 31 2023 n/a n/a US$6b
Dec 31 2022 US$21m US$2m US$6b
Sep 30 2022 n/a n/a US$6b
Jun 30 2022 n/a n/a US$6b
Mar 31 2022 n/a n/a US$6b
Dec 31 2021 US$19m US$2m US$6b
Sep 30 2021 n/a n/a US$6b
Jun 30 2021 n/a n/a US$4b
Mar 31 2021 n/a n/a US$5b
Dec 31 2020 US$17m US$1m US$5b
Sep 30 2020 n/a n/a US$5b
Jun 30 2020 n/a n/a US$6b
Mar 31 2020 n/a n/a US$5b
Dec 31 2019 US$15m US$1m US$5b
Sep 30 2019 n/a n/a US$4b
Jun 30 2019 n/a n/a US$4b
Mar 31 2019 n/a n/a US$4b
Dec 31 2018 US$14m US$1m US$4b
Sep 30 2018 n/a n/a US$5b
Jun 30 2018 n/a n/a US$4b
Mar 31 2018 n/a n/a US$4b
Dec 31 2017 US$3m US$162k US$4b
Compensación vs. Mercado: La compensación total de Gail($USD21.89M) está por encima de la media de empresas de tamaño similar en el mercado Austrian ($USD4.32M).
Compensación vs. Ingresos: La compensación de Gail ha sido consistente con los resultados de la empresa en el último año.
CEO US$21,889,039
Compensación Ms. Gail Koziara Boudreaux has been an Independent Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Elevance Health Inc. (formerly kn ... Show more
Equipo directivo Nombre Posición Permanencia Compensación Propiedad President 7yrs US$21.89m 0.047% € 43.6m Executive VP & CFO less than a year US$12.36m 0.0017% € 1.6m Executive VP and Chief Legal & Administrative Officer 4yrs US$8.11m 0.0044% € 4.1m Executive VP and President of Carelon & CarelonRx 10.4yrs US$6.98m 0.0071% € 6.5m Executive VP & President of Government Health Benefits 6.4yrs US$6.48m 0.0098% € 9.0m SVP, Treasurer & Chief Investment Officer 6.6yrs sin datos sin datos Senior VP 9yrs sin datos 0.00057% € 524.4k Vice President of Investor Relations no data sin datos sin datos Senior Vice President of Public Affairs 11yrs sin datos sin datos Chief Strategy Officer & Interim Chief Marketing Officer less than a year sin datos sin datos Executive VP & President of Commercial Health Benefits no data sin datos 0.0022% € 2.0m President of Dental Business 8yrs sin datos sin datos
Mostrar más
Equipo directivo experimentado: El equipo directivo de ELV es experimentado (6.8 años antigüedad media).
Miembros de la Junta Nombre Posición Permanencia Compensación Propiedad President 7yrs US$21.89m 0.047% € 43.6m Independent Director 20yrs US$386.76k 0.0024% € 2.2m Independent Chair of the Board 11.1yrs US$597.83k sin datos Independent Director 11.3yrs US$362.53k sin datos Independent Director 6.8yrs US$371.42k sin datos Independent Director 10.5yrs US$371.42k sin datos Independent Director 5.1yrs US$347.28k 0.0013% € 1.2m Independent Director 13.3yrs US$360.34k 0.0031% € 2.9m Member of Advisory Board 11.3yrs sin datos sin datos Member of Advisory Board 11.3yrs sin datos sin datos Member of Advisory Board 11.3yrs sin datos sin datos Member of Advisory Board 11.3yrs sin datos sin datos
Mostrar más
Junta con experiencia: Los miembros de la junta directiva de ELV son experimentados ( 11.3 años antigüedad media).
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}